Christine A. Nash, SVP & Chief Commercial Officer at HYPERION THERAPEUTICS INC (HPTX), sold 5,100 shares at $30.05 ($148K) on 2014-03-06, disclosed to the SEC on 2014-03-10.
Scheduled sale ($148k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.03 | 5,000 | $145K | 98.0% |
| 2 | $30.05 | 100 | $3K | 2.0% |
| Total | $29.05 avg | 5,100 | $148K | 100% |
| Filing → |
| HPTX | SELL | 2015-03-10 | $293K | — | Filing → |
| HPTX | SELL | 2015-01-22 | $124K | — | Filing → |
| HPTX | SELL | 2014-01-14 | $241K | — | Filing → |